Table 1.
Drug | Pre-treatment (h) | pEC50 | Emax | nH |
---|---|---|---|---|
Gemfibrozil | 24 | 5.9 ± 1.7 | 16.9 ± 3.5 | 1.4 ± 0.4 |
72 | 6.2 ± 0.1 | 41.7 ± 4.5 | 1.0 ± 0.1 | |
GW0742 | 24 | 8.0 ± 0.1 | 18.8 ± 1.4 | 1.0 ± 0.2 |
72 | 9.0 ± 0.1 | 36.4 ± 1.4 | 1.1 ± 0.2 | |
Pioglitazone | 24 | 7.0 ± 0.2 | 31.3 ± 2.2 | 1.7 ± 0.1 |
72 | 7.9 ± 0.1 | 58.2 ± 2.8 | 1.1 ± 0.2 |
Immortalized podocytes were pre-treated with gemfibrozil (0.01–30 µM), GW0742 (0.1 nM to 0.1 µM) or pioglitazone (1 nM to 1 µM) for either 24 h (a single treatment) or 72 h (as repeated treatments), then exposed to ND (5 h). At the end of the recovery phase (24 h), the number of viable cells was assessed to determine the ND-induced cell loss. Results are expressed as mean ± SEM. Mean of four experiments run in triplicate. Data were fitted as sigmoidal concentration–response curves and analysed with a four-parameter logistic equation.